PPLPHARMA2024-10-012024-12-31 PPLPHARMA2024-10-012024-12-31 PPLPHARMA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member PPLPHARMA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member PPLPHARMA2024-12-31 PPLPHARMA2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PPLPHARMA2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PPLPHARMA2024-10-012024-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PPLPHARMA2024-10-012024-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member PPLPHARMA2024-10-012024-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member PPLPHARMA2024-10-012024-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543635 PPLPHARMA NOTLISTED Piramal Pharma Limited Equity 2024-04-01 2025-03-31 2025-01-28 2025-01-13 INR Crores Third quarter 17:30:00 20:00:00 2025-01-28 2025-01-28 Not applicable Single segment Pharmaceuticals 2024-10-01 2024-12-31 Unaudited Consolidated 22042200000.00 121300000.00 22163500000.00 8054400000.00 1610600000.00 -1606700000.00 5562400000.00 1033100000.00 1968100000.00 5044100000.00 21666000000.00 497500000.00 0.00 497500000.00 719800000.00 -88600000.00 631200000.00 0.00 -133700000.00 0.00 0.00 0.00 170500000.00 36800000.00 150700000.00 187500000.00 36800000.00 0.00 150700000.00 0.00 13235800000.00 10 0.03 0.03 0.00 0.00 0.03 0.03 Refer to the unaudited consolidated financial statement submitted on 28th January, 2025 to the Stock Exchange Single segment 2024-04-01 2024-12-31 Unaudited Consolidated 63971100000.00 927800000.00 64898900000.00 18520600000.00 8706000000.00 -4459900000.00 16954600000.00 3179100000.00 5735800000.00 15411400000.00 64047600000.00 851300000.00 0.00 851300000.00 2163100000.00 -121000000.00 2042100000.00 0.00 -1190800000.00 0.00 0.00 0.00 567100000.00 -623700000.00 658800000.00 35100000.00 -623700000.00 0.00 658800000.00 0.00 13235800000.00 10 -0.47 -0.47 0.00 0.00 -0.47 -0.47 Other expenses, (Net) 5044100000.00 Other expenses, (Net) 15411400000.00 Remeasurement of Post Employment Benefit Plans -10500000.00 Remeasurement of Post Employment Benefit Plans -65400000.00 -10500000.00 -65400000.00 -2700000.00 -16500000.00 Deferred gains / (losses) on cash flow hedge -36800000.00 Exchange differences on translation of foreign operations 90900000.00 Deferred gains / (losses) on cash flow hedge -40600000.00 Exchange differences on translation of foreign operations 669100000.00 54100000.00 628500000.00 -104400000.00 -79200000.00